Search

everythinglearnresearchcommunity

for

Search:↓

Canakinumab's effect on COVID-19 outcomes is unclear.

Microneedles can cause side effects like infection and allergic reactions, and precautions like test spots and sunscreen are recommended.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Neuropathic pain is common in long COVID patients, especially those with depression or severe COVID-19.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

ABCD1 gene mutations cause adrenomyeloneuropathy, leading to symptoms like limb weakness and spasticity, with management focusing on rehabilitation and spasticity treatment.

Many hospitalized COVID-19 patients still have symptoms like fatigue and hair loss up to a year later, especially older, lower-income individuals with other health issues.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

MX1 and AR genes are linked to milder COVID-19, while TMPRSS2 increases severe risk, especially in women.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Genetic variants in PDE6H and LPAR6 cause vision impairment and hair loss in two Pakistani brothers.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

COVID-19 can increase the risk of hair loss, especially in people over 40.

Dihydrotestosterone boosts inflammation in fat cells more than testosterone.

Men with more CAG repeats in the androgen receptor gene and lower testosterone levels may experience more severe COVID-19.

One in four people still had symptoms like weight loss, hair loss, and fatigue 12-14 weeks after recovering from COVID-19.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

Vaccination reduces COVID-19 severity, and some symptoms like hair loss can persist for a year.

PRP injections are not proven effective for treating erectile dysfunction.

Long COVID is a complex condition with many symptoms and unknowns, needing more research.

Antiandrogens don't help with COVID-19 and aren't recommended.

Females are more likely than males to experience long-COVID symptoms and heart issues.

Genetic differences affect how people respond to COVID-19.

Different drugs are linked to specific mental health issues.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

COVID-19 may worsen Parkinson's disease by affecting certain brain proteins.

Inflammasome proteins can predict inflammation and outcomes in aneurysmal subarachnoid hemorrhage.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Most severe COVID-19 patients in Mexico experienced long-lasting symptoms that worsened their quality of life.